Jeffrey Scofield
Known title: DirectorCIK: 0001739835
Associated companies
Transaction History
| CVEO | ▲ Buy | Grant | 3,624 | $0 | 5/27/2026 | View on chart |
| CVEO | ▲ Buy | Grant | 5,618 | $0 | 11/26/2025 | View on chart |
| CVEO | ▲ Buy | Grant | 3,624 | $0 | 5/27/2026 | View on chart |
| CVEO | ▲ Buy | Grant | 5,618 | $0 | 11/26/2025 | View on chart |
We use analytics to understand how market-wall is used. No personal data is sold.
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 1, 2026
Civeo (CVEO) receives new analyst coverage and price targets
Roth Capital began coverage of Civeo and issued a $39 price target. Northland Capital also started coverage, assigning an Outperform rating and a $42 target. Both firms' reports add fresh analyst attention to the stock. The targets sit above the recent 52‑week high of $36.50, suggesting expectations of further upside.
Civeo (CVEO) receives new analyst coverage and price targets. Roth Capital began coverage of Civeo and issued a $39 price target. Northland Capital also started coverage, assigning an Outperform rating and a $42 target. Both firms' reports add fresh analyst attention to the stock. The targets sit above the recent 52‑week high of $36.50, suggesting expectations of further upside.